Efficacy and tolerability of lasmiditan, an oral 5-HT1F receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study

✍ Scribed by Markus Färkkilä; Hans-Christoph Diener; Gilles Géraud; Miguel Láinez; Jean Schoenen; Nadja Harner; Alison Pilgrim; Uwe Reuter

• Book ID: 114410015
• Publisher: The Lancet
• Year: 2012
• Tongue: English
• Weight: 242 KB
• Volume: 11
• Category: Article
• ISSN: 1474-4465
• DOI: 10.1016/s1474-4422(12)70047-9